A. Abbara, Frottis cervico-utérin (FCU) : définition, intérêts, rythme et conditions, 2013.

H. Ali, B. Donovan, H. Wand, T. Read, D. Regan et al., Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data, BMJ, vol.346, issue.apr18 1, p.2032, 2013.
DOI : 10.1136/bmj.f2032

URL : http://www.bmj.com/cgi/content/short/346/may07_5/f2942

A. Cervarix-ansm, Available from: http://ansm.sante.fr/Activites/Surveillance-des-medicaments/Medicaments-faisant-l-objet- d-un-plan-de-gestion-des-risques/Medicaments-faisant-l-objet-d-un-Plan-de-Gestion-des- Risques-PGR2, 2015.

A. Gardasil-ansm, Available from: http://ansm.sante.fr/Activites/Surveillance-des-medicaments/Medicaments-faisant-l-objet- d-un-plan-de-gestion-des-risques/Medicaments-faisant-l-objet-d-un-Plan-de-Gestion-des- Risques-PGR2, 2015.

F. Beck and A. Gauthier, Baromètre cancer 2010. Saint-Denis: INPES, p.272, 2010.

P. Bégué, M. Girard, H. Bazin, and J. Bach, Les adjuvants vaccinaux: quelle actualité en 2012? [Internet] Académie Nationale de Médecine; 2012 juin p. 32. Report No.: Comission VII (maladie infectieuses et médecine tropicale) Available from

D. Benabderrahmane and L. Abramowitz, Infection HPV et condylomes anaux état des lieux en 2006 : description, prévalence et prise en charge, Hépato-Gastro, vol.13, issue.3, pp.195-205, 2006.

D. Benabderrahmane and L. Abramowitz, Infection HPV et condylomes anaux État des lieux en 2005 : description, prévalence et prise en charge. Hépato-Gastro Oncol. Dig, pp.195-205, 2006.

C. Betsch, R. Böhm, and G. Chapman, Using Behavioral Insights to Increase Vaccination Policy Effectiveness, Policy Insights from the Behavioral and Brain Sciences, vol.20, issue.2, pp.61-73, 2015.
DOI : 10.1016/j.vaccine.2012.03.014

X. Castellsagué, F. Bosch, N. Muñoz, C. Meijer, K. Shah et al., Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners, New England Journal of Medicine, vol.346, issue.15, pp.1105-1117, 2002.
DOI : 10.1056/NEJMoa011688

X. Chen, R. Garcea, I. Goldberg, G. Casini, and S. Harrison, Structure of Small Virus-like Particles Assembled from the L1 Protein of Human Papillomavirus 16, Molecular Cell, vol.5, issue.3, 2000.
DOI : 10.1016/S1097-2765(00)80449-9

R. Cohen, V. L. Sage, F. Weil-olivier, C. , R. O. Hau et al., Plaidoyer pour un avancement de l?????ge de la vaccination contre les papillomavirus en France, Archives de P??diatrie, vol.19, pp.145-154, 2012.
DOI : 10.1016/S0929-693X(12)71289-7

N. Coleman, H. Birley, A. Renton, N. Hanna, B. Ryait et al., Immunological Events in Regressing Genital Warts, American Journal of Clinical Pathology, vol.102, issue.6, pp.768-74, 1994.
DOI : 10.1093/ajcp/102.6.768

P. Coursaget and A. Touzé, Les vaccins contre les papillomavirus. Virologie, pp.353-68, 2006.

R. Courseau, C. Ourghanlian, and D. Sismeiro, Chapitre 9: Infections sexuellement transmissibles. INFECTIOLOGIE. Vernazobres-Grego, pp.75-92, 2013.

J. Cox and A. Coulter, Adjuvants???a classification and review of their modes of action, Vaccine, vol.15, issue.3, pp.248-56, 1997.
DOI : 10.1016/S0264-410X(96)00183-1

R. Dachez, La cytologie cervico-utérine en milieu liquide: principes et applications, Rev. Fr. Histotechnol, vol.1, issue.13, pp.33-41, 2000.

F. Denis, S. Hanz, and A. S. , Clairance, persistance et récidive de l'infection à Papillomavirus. Gynécologie Obstétrique Fertil, pp.430-470, 2008.
DOI : 10.1016/j.gyobfe.2008.02.008

F. Dorleans, C. Giambi, L. Dematte, S. Cotter, P. Stefanoff et al., The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey, 2010.

M. Doutre, S. Barbarot, and F. Aubin, Item 149-Tumeurs cutanées épithéliales et mélaniques: tumeur à papillomavirus humain (HPV), Ann. Dermatol. Vénérologie, pp.140-145, 2005.

N. Duport and J. Viguier, Editorial du BEH thématique: Pathologie cervico-utérine: dépistage et surveillance des lésions précancéreuses et cancéreuses, BEH, pp.13-14, 2014.

M. Dürst, L. Gissmann, H. Ikenberg, and H. Zur-hausen, A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions., Proceedings of the National Academy of Sciences, vol.80, issue.12, pp.3812-3817, 1983.
DOI : 10.1073/pnas.80.12.3812

A. European-medicines, Available from, Juin. Report No, 2015.

L. Fonteneau, J. Guthmann, and D. Lévy-bruhl, Estimation des couvertures vaccinales en France à partir de l'Échantillon généraliste des bénéficiaires (EGB) : exemples de la rougeole, de l'hépatite B et de la vaccination HPV [Internet] Available from: http://www.invs.sante.fr/pmb/invs/(id)/PMB_11380 Food and Drug Administration. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV [Internet]. US Food Drug Adm, pp.8-9

S. Franceschi, X. Castellsagué, D. Maso, L. Smith, J. Plummer et al., Prevalence and determinants of human papillomavirus genital infection in men, British Journal of Cancer, vol.357, issue.5, pp.705-716, 2002.
DOI : 10.1038/sj.bjc.6600194

J. Fregnani, A. Carvalho, J. Eluf-neto, K. Ribeiro, C. De et al., A School-Based Human Papillomavirus Vaccination Program in Barretos, Brazil: Final Results of a Demonstrative Study, PLoS ONE, vol.30, issue.4, p.62647, 2013.
DOI : 10.1371/journal.pone.0062647.t003

S. Garland, S. Skinner, and J. Brotherton, Adolescent and young adult HPV vaccination in Australia: Achievements and challenges, Preventive Medicine, vol.53, issue.1, pp.29-35, 2011.
DOI : 10.1016/j.ypmed.2011.08.015

G. Anne, Infections à Papillomavirus [Internet]. 2012 Available from

A. Gouvernement-du-canada and C. De-la-santé-publique-du, Vaccin contre le virus du papillome humain -Partie 4 -Vaccins actifs -Guide canadien d'immunisation -Agence de la santé publique du Canada

I. Greslin, C. Mougin, and E. Seilles, Biologie des infections à papillomavirus. III. Réponse immunitaire, Ann. Biol. Clin, vol.56, issue.3, pp.267-76, 1998.

D. Harper, E. Franco, C. Wheeler, A. Moscicki, B. Romanowski et al., Sustained efficacy up to 4??5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial, The Lancet, vol.367, issue.9518, pp.1247-55, 2006.
DOI : 10.1016/S0140-6736(06)68439-0

I. Heard, V. Schmitz, D. Costagliola, G. Orth, and M. Kazatchkine, Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy, AIDS, vol.12, issue.12, pp.1459-64, 1998.
DOI : 10.1097/00002030-199812000-00007

C. Hobbs, J. C. Sterne, M. Bailey, R. S. Heyderman, M. A. Birchall et al., Human papillomavirus and head and neck cancer: a systematic review and meta-analysis, Clinical Otolaryngology, vol.96, issue.4, pp.259-66, 2006.
DOI : 10.1038/sj.onc.1205214

G. Ho, R. Bierman, L. Beardsley, C. Chang, and R. Burk, Natural History of Cervicovaginal Papillomavirus Infection in Young Women, New England Journal of Medicine, vol.338, issue.7, pp.423-431, 1998.
DOI : 10.1056/NEJM199802123380703

. Inca, Les traitements du cancer invasif du col de l'utérus: Guides patients Cancer Info, Juin, 2011.

. Inca, Chimiothérapie -Cancer du col de l'utérus | Institut National Du Cancer

. Inst, . Natl, and . Cancer, Available from: http://www.inpes.sante.fr/10000/themes/vaccination/guide-vaccination- 2012/telechargements.asp INPES. La santé des ados à la loupe -Publication des données françaises de l'enquête Health Behaviour in School-aged Children (HBSC) -Ministère des Affaires sociales Available from: http://www.sante.gouv.fr/la-sante-des-ados-a-la-loupe-publication-des-donnees-francaisesde-l-enquete-health-behaviour-in-school-aged-children-hbsc .html INPES, Chimiotherapie INPES. Guide des vaccinations 2012 [Internet]. 2012a Prévention des lésions précancéreuses et cancéreuses du col de l'utérus [Internet], p.2014, 2015.

. Inserm, Vaccins : Pourquoi font-ils peur ? 2015 Mar, Science & santé, issue.24, pp.22-33

I. Pasteur, P. Les-papillomavirus-appleby, V. Beral, A. Berrington-de-gonzález, D. Colin et al., Available from: http://www.pasteur.fr/fr/sante/info-hpv/les-papillomavirus International Collaboration of Epidemiological Studies of Cervical Cancer Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies, Lancet Lond. Engl, vol.370, issue.9599, pp.20141609-20141630, 2007.

M. Khan, P. Castle, A. Lorincz, S. Wacholder, M. Sherman et al., The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice, JNCI Journal of the National Cancer Institute, vol.97, issue.14, pp.1072-1081, 2005.
DOI : 10.1093/jnci/dji187

J. Ladner, M. Besson, M. Rodrigues, E. Audureau, and S. J. , Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009???2013, BMC Public Health, vol.133, issue.Suppl5, p.670, 2009.
DOI : 10.1177/1757913913499091

O. Launay and J. Monsonego, Vaccin HPV, la fin d'une polémique ? [Internet] Available from, 2016.

K. Louie, M. Didelot, and A. Damay, Papillomavirus humains (HPV) et cancers associ??s : aspects ??pid??miologiques, Revue Francophone des Laboratoires, vol.2008, issue.405, pp.27-34, 2008.
DOI : 10.1016/S1773-035X(08)74275-8

M. Maiman, R. Fruchter, L. Guy, S. Cuthill, P. Levine et al., Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer, pp.402-408, 1993.
DOI : 10.1002/1097-0142(19930115)71:2<402::aid-cncr2820710222>3.0.co;2-y

S. Majewski and S. Jablonska, Immunology of HPV infection and HPV-associated tumors, International Journal of Dermatology, vol.37, issue.2
DOI : 10.1046/j.1365-4362.1998.00435.x

L. Markowitz, S. Hariri, C. Lin, E. Dunne, M. Steinau et al., Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, J. Infect. Dis, vol.192, 2003.

C. Mendelson and A. Kligman, Isolation of Wart Virus in Tissue Culture, Archives of Dermatology, vol.83, issue.4, pp.559-62, 1961.
DOI : 10.1001/archderm.1961.01580100023003

F. Méndez, N. Muñoz, H. Posso, M. Molano, V. Moreno et al., Cervical Coinfection with Human Papillomavirus (HPV) Types and Possible Implications for the Prevention of Cervical Cancer by HPV Vaccines, The Journal of Infectious Diseases, vol.192, issue.7, pp.1158-65, 2005.
DOI : 10.1086/444391

G. Menvielle, D. Luce, B. Geoffroy-perez, J. Chastang, and A. Leclerc, Social inequalities and cancer mortality in France, Cancer Causes Control CCC, vol.16, issue.5, pp.1975-1990501, 2005.

L. Ministère-de and . Santé, Avis du Comité Technique des vaccinations et du Conseil Supérieur d'hygiène Publique de France (section des maladies transmissibles) relatif à la vaccination contre les Papillomavirus 6

. Genève, Département vaccination, vaccins et produits biologiques; 2012 19 avril Available from: http://www.who.int/reproductivehealth

D. M. Parkin and F. Bray, Chapter 2: The burden of HPV-related cancers, Vaccine, vol.24, pp.11-25, 2006.
DOI : 10.1016/j.vaccine.2006.05.111

P. Mclntyre, Finding the viral link: the story of Harald zur Hausen. CANCER WORLD, pp.32-39, 2005.

G. Ramon, Sur l'augmentation anormale de l'antitoxine chez les chevaux producteurs de sérum antidiphtériques, Bull Soc Centr Med Vet, issue.101, pp.227-261, 1925.

D. Riethmuller, A. Jacquard, J. Lacau-st-guily, F. Aubin, X. Carcopino et al., Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France, BMC Public Health, vol.134, issue.9, pp.4531-4538, 2000.
DOI : 10.1002/ijc.28541

URL : https://hal.archives-ouvertes.fr/hal-01153727

D. Riethmuller and E. Seilles, Immunité muqueuse du tractus génital féminin et mécanismes d'évasion des papillomavirus, pp.729-769, 2000.

J. Sadeyen, S. Tourne, M. Shkreli, P. Sizaret, and P. Coursaget, Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope, Virology, vol.309, issue.1, pp.32-40, 2003.
DOI : 10.1016/S0042-6822(02)00134-4

S. F. Culture, Politics, and Religion: Exploring Resistance to Vaccinations in South Asia, Hum. Welf, vol.1, pp.91-104, 2012.

S. Sanjosé, M. Diaz, X. Castellsagué, G. Clifford, L. Bruni et al., Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis, The Lancet Infectious Diseases, vol.7, issue.7, pp.453-462, 2007.
DOI : 10.1016/S1473-3099(07)70158-5

J. Sellors and R. Sankaranarayanan, Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginner's Manual, Int. Agency Res. Cancer Lyon, pp.1-138, 2003.

A. Taira, C. Neukermans, and G. Sanders, Evaluating Human Papillomavirus Vaccination Programs, Emerging Infectious Diseases, vol.10, issue.11, pp.1915-1938, 2004.
DOI : 10.3201/eid1011.040222

URL : http://doi.org/10.3201/eid1011.040222

. Thériaque, Monographie specialité: CONDYLINE 0,5% SOL FL 3,5ML -[Internet]. www.theriaque.org, 2014.

. Thériaque, Monographie specialité: ALDARA 5% CREME SACHET 250MG -[Internet]. www.theriaque.org, 2015.

H. Trottier, S. Mahmud, M. Costa, J. Sobrinho, E. Duarte-franco et al., Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.7, pp.1274-80, 2006.
DOI : 10.1158/1055-9965.EPI-06-0129

N. Van-de-velde, M. Brisson, and M. Boily, Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis, Vaccine, vol.28, issue.33, pp.5473-84, 2010.
DOI : 10.1016/j.vaccine.2010.05.056

D. Villiers, E. Fauquet, C. Broker, T. Bernard, H. Zur-hausen et al., Classification of papillomaviruses. Virology, pp.17-27, 2004.

X. Carcopino, C. Tamalet, D. Olive, J. Gondry, and L. Boubli, La charge virale: est-ce utile? Extr. Mises À Jours En Gynécologie Médicale, pp.521-555, 2009.

E. Yim and J. Park, The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis, Cancer Research and Treatment, vol.37, issue.6, pp.319-343, 2005.
DOI : 10.4143/crt.2005.37.6.319